-
Something wrong with this record ?
Molecular Genetic Aspects of Sporadic Multiglandular Primary Hyperparathyroidism
J. Včelák, Z. Šerková, K. Zajíčková
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
PubMed Central
from 2020
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Humans MeSH
- Molecular Biology MeSH
- Parathyroid Hormone genetics MeSH
- Parathyroid Glands pathology MeSH
- Hyperparathyroidism, Primary * diagnosis genetics pathology MeSH
- Retrospective Studies MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Multiglandular primary hyperparathyroidism (MGD) represents a rare form of primary hyperparathyroidism (PHPT). MGD is associated with hereditary PHPT, but the sporadic MGD is more common and affects a similar patient profile as single gland parathyroid disease (SGD). The distinction between SGD and MGD is of great clinical importance, especially for the strategy of parathyroidectomy. Based on the limited knowledge available, MGD is likely to be a genetically heterogeneous disease resulting from the interaction of germline and somatic DNA mutations together with epigenetic alterations. Furthermore, these events may combine and occur independently in parathyroid tumors within the same individual with MGD. Gene expression profiling has shown that SGD and MGD may represent distinct entities in parathyroid tumorigenesis. We are waiting for studies to analyze exactly which genes are different in SGD and MGD in order to identify potential biomarkers that can distinguish between the two forms of the disease.
1st Faculty of Medicine Charles University Czech Republic
2nd Faculty of Medicine Motol University Hospital Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022234
- 003
- CZ-PrNML
- 005
- 20250502125012.0
- 007
- ta
- 008
- 240104s2023 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.935253 $2 doi
- 035 __
- $a (PubMed)38116772
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Včelák, Josef, $d 1971- $7 xx0107261 $u Institute of Endocrinology, Prague, Czech Republic. kzajickova@endo.cz $u First Faculty of Medicine Charles University, Czech Republic
- 245 10
- $a Molecular Genetic Aspects of Sporadic Multiglandular Primary Hyperparathyroidism / $c J. Včelák, Z. Šerková, K. Zajíčková
- 520 9_
- $a Multiglandular primary hyperparathyroidism (MGD) represents a rare form of primary hyperparathyroidism (PHPT). MGD is associated with hereditary PHPT, but the sporadic MGD is more common and affects a similar patient profile as single gland parathyroid disease (SGD). The distinction between SGD and MGD is of great clinical importance, especially for the strategy of parathyroidectomy. Based on the limited knowledge available, MGD is likely to be a genetically heterogeneous disease resulting from the interaction of germline and somatic DNA mutations together with epigenetic alterations. Furthermore, these events may combine and occur independently in parathyroid tumors within the same individual with MGD. Gene expression profiling has shown that SGD and MGD may represent distinct entities in parathyroid tumorigenesis. We are waiting for studies to analyze exactly which genes are different in SGD and MGD in order to identify potential biomarkers that can distinguish between the two forms of the disease.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a primární hyperparatyreóza $x diagnóza $x genetika $x patologie $7 D049950
- 650 _2
- $a parathormon $x genetika $7 D010281
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a paratyreoidea $x patologie $7 D010280
- 650 _2
- $a molekulární biologie $7 D008967
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šerková, Zora $7 xx0329825 $u 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Zajíčková, Kateřina $7 xx0081901 $u Institute of Endocrinology, Prague, Czech Republic $u First Faculty of Medicine Charles University, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, Suppl. 4 (2023), s. S357-S363
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38116772 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20240104 $b ABA008
- 991 __
- $a 20250502125004 $b ABA008
- 999 __
- $a ok $b bmc $g 2283447 $s 1208678
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 72 $c S4 $d S357-S363 $e 2023Dec17 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
- LZP __
- $b NLK124 $a Pubmed-20240104